Robert Schulz, MD
Plastic and Reconstructive Surgery · Honolulu, HINPI 1760592729
Payments from drug & device makers
What this record shows
This record is dominated by other: $2,850 of the $4,409 with a category attached, or 64.6%. Integra Lifesciences Corporation accounts for 71.7% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2024 at $2,430 and has fallen 96.5% since, to $85 in 2025.
Across 26 payments — averaging $169.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$3K
- AbbVie$343
- Sientra, Inc.$203
- Polynovo North America LLC$179
- Sanara Medtech Inc.$147
- Smith+Nephew$145
- plus $231 from 5 others
What the payments were for
- Food & beverage$1,55935%
- Other$2,85065%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integra Lifesciences Corporation | 6 | $3,160 |
| AbbVie(2 entities) | 9 | $343 |
| Sientra, Inc. | 1 | $203 |
| Polynovo North America LLC | 3 | $179 |
| Sanara Medtech Inc. | 1 | $147 |
| Smith+Nephew | 1 | $145 |
| Medline Industries LP | 1 | $80 |
| TELA Bio, Inc. | 1 | $54 |
| Davol Inc. | 1 | $51 |
| Avita Medical Americas, LLC | 1 | $34 |
| Mentor Worldwide LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few plastic and reconstructive surgery providers in Hawaiito place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 31 | $172 |
| Mupirocin | 12 | $81 |
| Ondansetron Hcl | 14 | $62 |
| Cephalexin | 11 | $39 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Honolulu
- Shim ChingHonolulu$49K
- Peter DeptulaHonolulu$18K
- Randolph WongHonolulu$7K
- Vincent NipHonolulu$7K
- Zachary LongHonolulu$2K
- Matthew AdaniyaHonolulu$2K
- Michael PasqualeHonolulu$904
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.